EPIRUS Biopharmaceuticals Aktie Analyse
11.05.16 | EPIRUS Biopharmaceuticals Neutral | Wedbush Morgan Securities Inc. | |
16.03.16 | EPIRUS Biopharmaceuticals Outperform | Wedbush Morgan Securities Inc. |
11.05.16 | EPIRUS Biopharmaceuticals Neutral | Wedbush Morgan Securities Inc. | |
16.03.16 | EPIRUS Biopharmaceuticals Outperform | Wedbush Morgan Securities Inc. |